Evidence map›Paper›PMID 29610465›Full record

ArticleNature chemistry2018

A general strategy for synthesis of cyclophane-braced peptide macrocycles via palladium-catalysed intramolecular sp

Xuekai Zhang, Gang Lu, Meng Sun, Madhu Mahankali, Yanfei Ma, Mingming Zhang, Wangde Hua, Yuting Hu, Qingbing Wang, Jinghuo Chen and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
10.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 242 citations in OpenAlex.

  1. Pd(II)-Catalyzed Strategies for the β-Arylation of α-Amino Acids: An Overview.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. De novo discovery of a molecular glue-like macrocyclic peptide that induces MCL1 homodimerization.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Peptide macrocyclisationChemical science · 2024
    Article
  10. Article
  11. Article
  12. MacrocyclizationChemical science · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Xuekai ZhangState Key Laboratory and Institute of Elemento-Organic Chemistry, College of Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin, China.
Gang LuDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA.
Meng SunNational Institute of Biological Sciences, Beijing, China.
Madhu MahankaliCalifornia Institute for Biomedical Research, La Jolla, CA, USA.
Yanfei MaState Key Laboratory and Institute of Elemento-Organic Chemistry, College of Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin, China.
Mingming ZhangState Key Laboratory and Institute of Elemento-Organic Chemistry, College of Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin, China.
Wangde HuaState Key Laboratory and Institute of Elemento-Organic Chemistry, College of Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin, China.
Yuting HuState Key Laboratory and Institute of Elemento-Organic Chemistry, College of Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin, China.
Qingbing WangState Key Laboratory and Institute of Elemento-Organic Chemistry, College of Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin, China.
Jinghuo ChenState Key Laboratory and Institute of Elemento-Organic Chemistry, College of Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin, China.
Gang HeState Key Laboratory and Institute of Elemento-Organic Chemistry, College of Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin, China. hegang@nankai.edu.cn.
Xiangbing QiNational Institute of Biological Sciences, Beijing, China. qixiangbing@nibs.ac.cn.ORCID http://orcid.org/0000-0002-7139-5164
Weijun ShenCalifornia Institute for Biomedical Research, La Jolla, CA, USA. wshen@calibr.org.
Peng LiuDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA. pengliu@pitt.edu.ORCID http://orcid.org/0000-0002-8188-632X
Gong ChenState Key Laboratory and Institute of Elemento-Organic Chemistry, College of Chemistry, Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Nankai University, Tianjin, China. gongchen@nankai.edu.cn.ORCID http://orcid.org/0000-0002-5067-9889
Nankai University · CNCalifornia Institute for Biomedical Research · USNational Institute of Biological Sciences, Beijing · CNUniversity of Pittsburgh · USPennsylvania State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New methods capable of effecting cyclization, and forming novel three-dimensional structures while maintaining favourable physicochemical properties are needed to facilitate the development of cyclic peptide-based drugs that can engage challenging biological targets, such as protein-protein interactions. Here, we report a highly efficient and generally applicable strategy for constructing new types of peptide macrocycles using palladium-catalysed intramolecular C(sp

Indexed as

CarbonCatalysisCell Line, TumorCyclizationDensity Functional TheoryEthers, CyclicHumansHydrogenMacrocyclic CompoundsPalladiumPeptidesCarbonEthers, CyclicHydrogenMacrocyclic CompoundsPalladiumPeptides

Identifiers

PMID29610465
OpenAlexW2794590245

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.